Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

BHMT remethylates homocysteine to methionine using choline-derived betaine.

BHMT acts as a folate-independent backup pathway that uses betaine from choline to remethylate homocysteine into methionine, and reduced BHMT function increases susceptibility to elevated homocysteine.

SupportedJune 19, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

BHMT uses betaine derived from choline to remethylate homocysteine to methionine as a folate‑independent backup pathway, and reduced BHMT function can increase susceptibility to higher homocysteine.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a folate-independent remethylation route in which choline is converted to betaine, and BHMT transfers a methyl group from betaine to homocysteine to form methionine. The mechanism emphasizes liver/kidney localization of this pathway and notes that impaired BHMT activity or genetic variants that reduce its function lead to homocysteine accumulation and related metabolic consequences.

Verified conclusion

The mechanism by which the body regulates homocysteine involves two primary pathways: the folate-dependent cycle and the folate-independent betaine-homocysteine S-methyltransferase (BHMT) pathway. Scientific evidence strongly supports the role of BHMT as a critical backup system that utilizes betaine—a derivative of choline—to recycle homocysteine into methionine.

Mechanistic pathways

Homocysteine metabolism relies on the transfer of methyl groups. While the standard pathway utilizes 5-methyltetrahydrofolate (the active form of folate) and vitamin B12, the BHMT pathway functions independently of these nutrients.

  • Choline-Betaine Axis: Choline is first oxidized to betaine aldehyde and then to betaine (glycine betaine) within the liver.
  • Enzymatic Catalysis: BHMT transfers a methyl group from betaine to homocysteine. This reaction produces methionine and dimethylglycine (DMG).
  • Tissue Specificity: This folate-independent pathway is highly concentrated in the liver and the kidney cortex, where it can account for up to 50% of total homocysteine remethylation activity.

Impact of reduced BHMT function

When BHMT activity is compromised, the body's ability to normalize homocysteine levels is significantly diminished, particularly when the folate-dependent pathway is under stress.

  • Homocysteine Accumulation: Biochemical studies and knockout models demonstrate that a significant reduction in BHMT activity leads to dramatic increases in plasma homocysteine. Total deletion of the BHMT gene can result in homocysteine levels increasing 8-fold.
  • Genetic Susceptibility: Human genetic variants (polymorphisms) in the BHMT gene are associated with altered metabolic efficiency. For example, specific genotypes are linked to a higher risk of failing to lower homocysteine despite folate supplementation, as the "backup" pathway cannot compensate for the load.
  • Metabolic Consequences: Impaired BHMT function not only raises homocysteine (hyperhomocysteinemia) but also depletes choline metabolites, which is linked to increased risks of fatty liver and cellular damage.

Bottom line

BHMT serves as a vital folate-independent backup for homocysteine regulation by using choline-derived betaine. Any reduction in BHMT efficiency directly increases susceptibility to elevated homocysteine, as the body loses its primary alternative remethylation route.

References

  1. Synthesizing glycine betaine via choline oxidation pathway as an osmoprotectant strategy in Haloferacales. — linkinghub.elsevier.com ↗
  2. Production of recombinant choline oxidase and its application in betaine production — pmc.ncbi.nlm.nih.gov ↗
  3. Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. — pmc.ncbi.nlm.nih.gov ↗
  4. Dissecting the catalytic mechanism of betaine-homocysteine S-methyltransferase by use of intrinsic tryptophan fluorescence and site-directed mutagenesis. — pubs.acs.org ↗
  5. Protective effect of betaine against liver steatosis involves depletion of homocysteine via upregulation of betaine‐homocysteine methyltransferase (BHMT) — faseb.onlinelibrary.wiley.com ↗
  6. Betaine–homocysteine methyltransferase promotes adipocyte commitment and insulin resistance via p38 MAPK/Smad signaling — onlinelibrary.wiley.com ↗
  7. Betaine Homocysteine Methyltransferase Is Active in the Mouse Blastocyst and Promotes Inner Cell Mass Development* — linkinghub.elsevier.com ↗
  8. Molecular characterization and analysis of the porcine betaine homocysteine methyltransferase and betaine homocysteine methyltransferase-2 genes. — pmc.ncbi.nlm.nih.gov ↗
  9. Components of the Choline Oxidation Pathway Modify the Association Between the Apolipoprotein ε4 Gene Variant and Cognitive Decline in Patients with Dementia. — linkinghub.elsevier.com ↗
  10. Inhibition of betaine-homocysteine S-methyltransferase in rats causes hyperhomocysteinemia and reduces liver cystathionine β-synthase activity and methylation capacity. — pmc.ncbi.nlm.nih.gov ↗
  11. Dietary intake of S-(alpha-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats. — pmc.ncbi.nlm.nih.gov ↗
  12. Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas* — jbc.org ↗
  13. Homocysteine-induced endoplasmic reticulum stress activates FGF21 and is associated with browning and atrophy of white adipose tissue in Bhmt knockout mice — linkinghub.elsevier.com ↗
  14. Association between the BHMT gene rs3733890 polymorphism and the efficacy of oral folate therapy in patients with hyperhomocysteinemia — onlinelibrary.wiley.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→